Your session is about to expire
← Back to Search
Behavioral Intervention
Augmented Reality Training for Emergency Response
N/A
Waitlist Available
Research Sponsored by Thomas Caruso
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of intervention (less than one hour)
Awards & highlights
Study Summary
This trial evaluates how prehospital providers respond to simulation training using Augmented Reality (AR) technology.
Who is the study for?
This trial is for trainees and faculty aged 18 or older working at LPCH/SHC facilities, including community-based prehospital providers. It's not suitable for those who are pregnant, have a history of seizures or severe motion sickness, are clinically unstable, don't consent to participate, use corrective glasses (incompatible with AR headset), or currently experience nausea.Check my eligibility
What is being tested?
The study tests the use of an Augmented Reality (AR) Headset as a training tool for prehospital providers. The focus is on how these providers interact with and accept AR technology during simulations that teach them about managing conditions like low blood sugar and acute lymphoblastic leukemia.See study design
What are the potential side effects?
While the study itself may not cause direct side effects from medical interventions, participants should be aware that using an AR headset could potentially lead to discomfort such as eye strain or headaches due to its immersive nature.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ duration of intervention (less than one hour)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of intervention (less than one hour)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Thematic Analysis of Post-Simulation Discussions
Secondary outcome measures
Headset Ergonomics
System Usability Scale (SUS)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Augmented Reality Enhanced Simulation (Treatment group)Experimental Treatment1 Intervention
Each simulation will have between two and five participants. After consent, demographic data will be collected. Then, a study RA will fit a Magic Leap One (ML1) headsets (Magic Leap Inc., Plantation, FL) to participants. Following a scripted briefing, the instructor will also orient the participants to the ML1 headset for those in that group. After orienting the participant to the use of the headsets, the instructor will remain in a room separate from the participants, who will conduct the scenario outside. This will enable assessment of the feasibility of providing simulation instruction remotely. Prior to starting the scenario, the simulation instructor will conduct an orientation to review the core tenets of effective communication skills during prehospital care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Augmented Reality Headset
2023
N/A
~150
Find a Location
Who is running the clinical trial?
Thomas CarusoLead Sponsor
1 Previous Clinical Trials
200 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of seizures.You have a history of getting very sick from motion.People who work or volunteer at LPCH/SHC facilities and prehospital providers in the community.I am currently experiencing nausea.You are not in a stable medical condition.I am 18 years old or older.You wear glasses that can't be used with the augmented reality headset.
Research Study Groups:
This trial has the following groups:- Group 1: Augmented Reality Enhanced Simulation (Treatment group)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this clinical investigation require additional participants?
"The information on clinicaltrials.gov confirms that enrollment in this medical study has been closed as of January 6th 2023, despite the fact it was first posted on December 12th 2022. Fortunately, 115 other trials are actively recruiting participants at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger